The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary

The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary

書誌詳細
主要な著者:	Yusuf, IH, Foot, B, Lotery, AJ
フォーマット:	Journal article
言語:	English
出版事項:	Springer Nature 2021

類似資料

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary
著者:: Yusuf, IH, 等
出版事項: (2018)

Joint recommendations for retinal screening in long‐term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018
著者:: Yusuf, IH, 等
出版事項: (2018)

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
著者:: Yusuf, IH, 等
出版事項: (2018)

Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom
著者:: Yusuf, I, 等
出版事項: (2021)

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
著者:: Lotery, A, 等
出版事項: (2018)

New recommendations for retinal monitoring in hydroxychloroquine users: Baseline testing is no longer supported
著者:: Yusuf, IH, 等
出版事項: (2021)

Chloroquine, hydroxychloroquine and COVID-19
著者:: Erickson, T. B., 等
出版事項: (2020)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
著者:: David M. Stevens, 等
出版事項: (2020-12-01)

Coding patterns used by ophthalmologists for hydroxychloroquine retinal toxicity
著者:: Chiu SY, 等
出版事項: (2018-11-01)

The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
著者:: Yusuf, IH, 等
出版事項: (2024)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
著者:: Tzu-Chuan Ho, 等
出版事項: (2021-02-01)

Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease
著者:: Julia Prinz, 等
出版事項: (2023-06-01)

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
著者:: Jacob A. Lebin, 等
出版事項: (2020-07-01)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
著者:: Javad Mahmoudi, 等
出版事項: (2021-01-01)

The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
著者:: Carolina Pereira Fernandes, 等
出版事項: (2022-01-01)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
著者:: Vincent Gies, 等
出版事項: (2020-07-01)

Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation
著者:: Belayneh A
出版事項: (2020-09-01)

Chloroquine and Hydroxychloroquine: Potentially Inappropriate Medications for Older Adults?
著者:: Milton Gorzoni
出版事項: (2024-10-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
著者:: Carlos Enrique Salgado-Fuentes
出版事項: (2021-05-01)

Prophylactic Effect of Chloroquine and Hydroxychloroquine on COVID-19 Treatment
著者:: Amin Ataie, 等
出版事項: (2022-04-01)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
著者:: Timothy J. Kamp, 等
出版事項: (2020-06-01)

Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
著者:: Elie Naddaf, 等
出版事項: (2021-02-01)

The mechanism of chloroquine/hydroxychloroquine and its application in stomatological diseases
著者:: LIN Lin, 等
出版事項: (2021-03-01)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
著者:: Rosa Camila Lucchetta, 等
出版事項: (2020-04-01)

Royal College recommendations to improve academic anesthesia in the United kingdom: how they compare with United States proposals.
著者:: Pandit, J
出版事項: (2006)

Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine
著者:: Seidu A. Richard, 等
出版事項: (2020-01-01)

Hydroxychloroquine and chloroquine for COVID-19 infection. Rapid systematic review
著者:: Rafael Leite Pacheco, 等
出版事項: (2020-03-01)

Use of chloroquine and hydroxychloroquine in COVID-19 patients: A dilemma
著者:: Archana Bhatia, 等
出版事項: (2022-01-01)

Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
著者:: Jarir At Thobari
出版事項: (2021-08-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
著者:: Pathiyil Ravi Shankar, 等
出版事項: (2021-01-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
著者:: Elangovan Manivannan, 等
出版事項: (2021-05-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
著者:: Babayeva M, 等
出版事項: (2020-10-01)

Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies
著者:: R.L. Schroeder, 等
出版事項: (2014-01-01)

Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy
著者:: Chandler, L, 等
出版事項: (2020)

Thinking outside the circle—the potential value of ultra-widefield imaging
著者:: Yusuf, IH, 等
出版事項: (2022)

Retinal Toxicity and the Use of Hydroxychloroquine and Chloroquine in the Current Management of COVID-19
著者:: Romulo N. Aguilar, MD, PhD, 等
出版事項: (2020-06-01)

Early detection of the retinal bioelectrical dysfunction in patients treated by chloroquine/hydroxychloroquine
著者:: Wojciech Lubiński, 等
出版事項: (2024-12-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
著者:: Muhammad Haroon Aftab, 等
出版事項: (2024-01-01)

Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
著者:: Alessandra Costanza, 等
出版事項: (2021-11-01)

Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
著者:: Christina B. Klouda, 等
出版事項: (2020-09-01)